<DOC>
	<DOCNO>NCT00810836</DOCNO>
	<brief_summary>The purpose study investigate whether drug BG00012 improve symptom rheumatoid arthritis ( RA ) patient already take methotrexate RA , still suffer symptom RA . The purpose also ensure combination methotrexate safe patient take side effect acceptable patient RA .</brief_summary>
	<brief_title>Efficacy Safety Study BG00012 With Methotrexate Patients With Active Rheumatoid Arthritis</brief_title>
	<detailed_description>The study double-blind , placebo-controlled study BG00012 plus methotrexate , versus methotrexate alone , patient active RA , incomplete response conventional disease modify anti-rheumatic ( DMARD ) therapy .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Dimethyl Fumarate</mesh_term>
	<mesh_term>Antirheumatic Agents</mesh_term>
	<criteria>must take methotrexate inadequate response least one conventional DMARD swollen tender joint count previous treatment TNF biologic prosorba column Other criterion also apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2011</verification_date>
</DOC>